Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients

被引：0
|
作者：
Eiji Shinto
Eiji Oki
Mototsugu Shimokawa
Shigeki Yamaguchi
Megumi Ishiguro
Seiji Hasegawa
Yasumasa Takii
Hideyuki Ishida
Tetsuya Kusumoto
Masaru Morita
Naohiro Tomita
Manabu Shiozawa
Masafumi Tanaka
Heita Ozawa
Yojiro Hashiguchi
Shinobu Ohnuma
Sachiyo Tada
Tomoko Matsushima
Keisuke Yamagishi
Kazuo Hase
机构：
[1] National Defense Medical College,Department of Surgery
[2] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences
[3] Yamaguchi University Graduate School of Medicine,Department of Biostatistics
[4] Tokyo Women’s Medical University,Department of Surgery, Division of Colorectal Surgery
[5] Tokyo Medical and Dental University,Medical Innovation Promotion Center
[6] Saiseikai Yokohamashi Nanbu Hospital,Department of Surgery
[7] Niigata Cancer Center Hospital,Department of Gastroenterological Surgery
[8] Saitama Medical Center,Department of Digestive Tract and General Surgery
[9] Saitama Medical University,Department of Gastroenterological Surgery, Clinical Research Center, Cancer Research Division
[10] National Hospital Organization Kyushu Medical Center,Department of Gastroenterological Surgery
[11] National Hospital Organization Kyushu Cancer Center,Cancer Treatment Center
[12] Toyonaka Municipal Hospital,Department of Gastrointestinal Surgery
[13] Kanagawa Cancer Center,Coloproctology Center
[14] Takano Hospital,Department of Colorectal Surgery
[15] Tochigi Cancer Center,Department of Surgery
[16] Teikyo University School of Medicine,Department of Surgery
[17] Tohoku University Hospital,LS Business
[18] Sysmex Corporation,undefined
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5239 / 5247
页数：8
相关论文
共 50 条
  • [21] Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
    Zaoqu Liu
    Taoyuan Lu
    Jing Li
    Libo Wang
    Kaihao Xu
    Qin Dang
    Chunguang Guo
    Long Liu
    Dechao Jiao
    Zhenqiang Sun
    Xinwei Han
    Cancer Cell International, 21
  • [22] Tumor budding as an index to identify high-risk patients with stage II colon cancer
    Nakamura, Takatoshi
    Mitomi, Hiroyuki
    Kanazawa, Hideki
    Ohkura, Yasuo
    Watanabe, Masahiko
    DISEASES OF THE COLON & RECTUM, 2008, 51 (05) : 568 - 572
  • [23] Prognostic value of tumor budding in patients with stage II and III colon cancer: A singleinstitution experience.
    Vinal, David
    Rueda-Lara, Antonio
    Martinez-Perez, Daniel
    Zwisler, Patricia
    Garcia-Leal, Andrea
    Ruiz-Gutierrez, Iciar
    Jimenez-Bou, Diego
    Pena-Lopez, Jesus
    Alameda-Guijarro, Maria
    Martin-Montalvo, Gema
    Perez-Wert, Pablo
    Martinez-Recio, Sergio
    Elena Palacios, Maria
    Ghanem, Ismael
    Custodio, Ana B.
    Gutierrez-Sainz, Laura
    Feliu, Jaime
    Rodriguez Salas, Nuria
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 247 - 247
  • [24] A robust circular RNA-based prognostic signature for postoperative recurrence in stage II/III colon cancer
    Ruan, Ji
    AIMS GENETICS, 2019, 6 (04): : 67 - 69
  • [25] Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
    Bockelman, Camilla
    Engelmann, Bodil E.
    Kaprio, Tuomas
    Hansen, Torben F.
    Glimelius, Bengt
    ACTA ONCOLOGICA, 2015, 54 (01) : 5 - 16
  • [26] Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
    Roth, Arnaud D.
    Delorenzi, Mauro
    Tejpar, Sabine
    Yan, Pu
    Klingbiel, Dirk
    Fiocca, Roberto
    d'Ario, Giovanni
    Cisar, Laura
    Labianca, Roberto
    Cunningham, David
    Nordlinger, Bernard
    Bosman, Fred
    Van Cutsem, Eric
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (21): : 1635 - 1646
  • [27] A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer
    Ma, Jian
    Yang, Burton B.
    CANCER COMMUNICATIONS, 2019, 39 (01)
  • [28] Immunomonitoring in patients with stage II and III colon cancer
    Vocka, Michal
    Spacek, Jan
    Netikova, Irena
    Zavadova, Eva
    Nemejcova, Kristyna
    Konopasek, Bohuslav
    Dundr, Pavel
    Geppert, Carol-Immanuel
    Fucikova, Terezie
    Hartmann, Arndt
    Petruzelka, Lubos B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer
    P Bohanes
    D Yang
    F Loupakis
    M J LaBonte
    A Gerger
    Y Ning
    C Lenz
    F Lenz
    T Wakatsuki
    W Zhang
    L Benhaim
    A El-Khoueiry
    R El-Khoueiry
    H-J Lenz
    The Pharmacogenomics Journal, 2015, 15 : 226 - 234
  • [30] Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer
    Bohanes, P.
    Yang, D.
    Loupakis, F.
    LaBonte, M. J.
    Gerger, A.
    Ning, Y.
    Lenz, C.
    Lenz, F.
    Wakatsuki, T.
    Zhang, W.
    Benhaim, L.
    El-Khoueiry, A.
    El-Khoueiry, R.
    Lenz, H-J
    PHARMACOGENOMICS JOURNAL, 2015, 15 (03): : 226 - 234
12345